Patents by Inventor Natalie June Medlicott

Natalie June Medlicott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended Release Pharmaceutical Formulation
    Publication number: 20230355548
    Abstract: The disclosure provides a dosing regimen utilizing an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: September 22, 2020
    Publication date: November 9, 2023
    Inventors: Paul William Glue, Natalie June Medlicott, Peter William Surman
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20220387355
    Abstract: The disclosure provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: August 9, 2022
    Publication date: December 8, 2022
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
    Publication number: 20220354798
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Application
    Filed: June 28, 2022
    Publication date: November 10, 2022
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
    Publication number: 20220347104
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Application
    Filed: June 28, 2022
    Publication date: November 3, 2022
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • Extended release pharmaceutical formulation and methods of treatment
    Patent number: 11471415
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: October 18, 2022
    Assignee: Douglas Pharmaceuticals, Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott, Peter William Surman
  • Extended release pharmaceutical formulation and methods of treatment
    Patent number: 11471416
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Grant
    Filed: June 2, 2020
    Date of Patent: October 18, 2022
    Assignee: Douglas Pharmaceuticals, Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott, Peter William Surman
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20220183983
    Abstract: The disclosure provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 16, 2022
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • Extended release pharmaceutical formulation
    Patent number: 11045424
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: June 29, 2021
    Assignee: Douglas Pharmaceuticals Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott, Peter William Surman
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20210052517
    Abstract: The disclosure provides a dosing regimen utilizing an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: September 24, 2020
    Publication date: February 25, 2021
    Inventors: Paul William Glue, Natalie June Medlicott, Yuefeng Long
  • Extended release pharmaceutical formulation
    Patent number: 10869838
    Abstract: The disclosure provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: December 22, 2020
    Assignee: Douglas Pharmaceuticals, Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
    Publication number: 20200323795
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Application
    Filed: June 2, 2020
    Publication date: October 15, 2020
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT
    Publication number: 20200306194
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia.
    Type: Application
    Filed: October 10, 2018
    Publication date: October 1, 2020
    Inventors: Paul William GLUE, Natalie June MEDLICOTT, Peter William SURMAN
  • Extended release pharmaceutical formulation
    Patent number: 10744094
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: August 18, 2020
    Assignee: Douglas Pharmaceuticals, Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20200000731
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: September 10, 2019
    Publication date: January 2, 2020
    Inventors: Paul William Glue, Natalie June Medlicott
  • Extended release pharmaceutical formulation
    Patent number: 10441544
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: October 15, 2019
    Assignee: Douglas Pharmaceuticals, Ltd.
    Inventors: Paul William Glue, Natalie June Medlicott, Peter William Surman
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20190224127
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: March 28, 2019
    Publication date: July 25, 2019
    Inventors: Paul William Glue, Natalie June Medlicott
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20190216740
    Abstract: The disclosure provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: March 25, 2019
    Publication date: July 18, 2019
    Inventors: Paul William Glue, Natalie June Medlicott
  • EXTENDED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20190105276
    Abstract: The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
    Type: Application
    Filed: October 10, 2017
    Publication date: April 11, 2019
    Inventors: Paul William Glue, Natalie June Medlicott